DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures ...
Introduction Colorectal cancer (CRC) screening reduces cancer incidence and mortality, but participation rates are suboptimal ...
Morning Overview on MSN
A triple-hormone shot helped patients lose 70 pounds in a major obesity trial
Adults with obesity who received the highest dose of retatrutide, a triple-hormone injection, lost roughly 24 percent of ...
Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
"Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses" was originally created and published by Clinical ...
The primary objective of the study is to evaluate the efficacy of Thykamine™ compared with placebo in the treatment of ...
Study did not meet key efficacy objectives Favorable safety profile consistent with prior studies, including with new 450mg loading dose and up ...
An increase in dietary spermidine intake over 1 year is associated with improvements in hepatic function and cardiometabolic ...
Devonian Health Group Inc. ("Devonian" or the "Company") , a clinical-stage biopharmaceutical company focused on developing innovative therapies targeting fibro-inflammatory diseases, today announced ...
Zydus Lifesciences Limited, an innovation-led global lifesciences company, has received permission to conduct a phase III clinical trial of Desidustat for patients with sickle cell disease. Conducted ...
Zydus Lifesciences Limited (Zydus), an innovation-led global lifesciences company, has received permission to conduct a Phase ...
Patients with Parkinson’s disease experienced “significant and clinically meaningful” improvements in motor symptoms over 27 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results